Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions

10 Oct 2000

Abstract excerpt

OBJECTIVE: To assess the efficacy, tolerability, and safety of riluzole in the treatment of peripheral neuropathic pain conditions. BACKGROUND: Both basic and clinical research has demonstrated that drugs with sodium channel and NMDA antagonism can be effective in alleviating neuropathic pain. Riluzole, a drug currently used for treatment of ALS, possesses these properties. It was hypothesized that riluzole would...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Musculoskeletal pain and rehabilitation
Share to Pain Management and Opioid Use
Share to Pain Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11061253
DOI: 10.1212/wnl.55.7.971

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditionsPMID 11061253Read ↗

The effect of lacosamide in peripheral neuropathic pain: A randomized, double-blind, placebo-controlled, phenotype-stratified trial.Semantic proximity Read ↗

Riluzole treatment paradoxically increases motoneuron excitability in ALS due to hyperactive homeostasisSemantic proximity Read ↗

Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice.Semantic proximity Read ↗

Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS.Semantic proximity Read ↗

Lu 25-109, a muscarinic agonist, fails to improve cognition in Alzheimer's disease. Lu25-109 Study Group.Semantic proximity Read ↗

Future directions in neuropathic pain therapy: closing the translational loop.Semantic proximity Read ↗

Riluzole does not ameliorate disease caused by cytoplasmic TDP-43 in a mouse model of amyotrophic lateral sclerosisSemantic proximity Read ↗

Evaluation of Clinical Outcomes of Riluzole monotherapy and Riluzole based adjunctive interventions in Amyotrophic Lateral Sclerosis: A meta-analytic and unsupervised clustering approachSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.